Health care delivery in the older person with cancer

Critical Reviews in Oncology/Hematology

Volumn 35, Issue 3, 2000, Pages 227-232

  Zulian, Gilbert B ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Cancer; Care; Genetic predisposition; Prevention

Indexed keywords

AGING; CANCER; CANCER DIAGNOSIS; CANCER PREVENTION; GENETIC PREDISPOSITION; HEALTH CARE DELIVERY; LIFE EXPECTANCY; PALLIATIVE THERAPY; REVIEW; RISK FACTOR;

EID: 0033847752     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(99)00068-2     Document Type: Article

References (33)

1. Le cancer à Genève. Incidence, mortalité, survie, 1970-1994. Registre genevois des tumeurs, Département de l'Action Sociale et de la Santé, République et Canton de Genève, Genève, 1997. p. 12-29.
2. Monfardini S. What do we know on variables influencing clinical decision-making in elderly cancer patients. Eur. J. Cancer. 32A:1996;12-14.
3. Yancik R., Ries L.A. Cancer in the older persons: magnitude of the problems-how do we apply what we know? Cancer. 74:1994;1995-2003.
4. Fears R., Poste G. Building population genetics ressources using the UK NHS. Science. 284:1999;267-281.
5. Li J.Y., Taylor P.R., Dawsey S., et al. Nutrition intervention trial in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J. Natl. Cancer Inst. 85:1993;1492-1498.
6. Doll R., Peto R. The causes of cancer. J. Natl. Cancer Inst. 66:1981;1191-1308.
7. Cummings SR, Norton L, Eckert S, et al. Raloxifene reduces the risk of breast cancer and may decrease the risk of endometrial cancer in post-menopausal women. Two-year findings from the multiple outcomes of raloxifene evaluation (MORE) trial. Proceedings of ASCO 17:2a (abstract 3), 1998.
8. Law M.R., Morris J.K., Wald N.J. The importance of age in screening for cancer. J. Med. Screen. 6:1999;16-20.
9. Norum J. Breast cancer screening by mammography in Norway: is it cost-effective? Ann. Oncol. 10:1999;197-203.
10. Nyström L., Rutqvist L.E., Wall S., et al. Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet. 341:1993;973-978.
11. De Antoni E.P. Eight years of prostate cancer awareness week: lessons in screening and early detection: Prostate Cancer Education Council. Cancer. 80:1997;1845-1851.
12. Mettlin C.J., Murphy G.P., Babaian R.J., et al. Observations on the early detection of prostate cancer from the American Cancer Society National Prostate Cancer Detection Project. Cancer. 80:1997;1814-1817.
13. Mandel J.S., Church T.R., Ederer F., et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J. Natl. Cancer Inst. 91:1999;434-437.
14. Mahlck C.G., Johnson H., Lenner P. Pap smear screening and changes in cervical cancer mortality in Sweden. Int. J. Gynaecol. Obstet. 44:1994;267-272.
15. Fentiman I.S., Tirelli U., Monfardini S., et al. Cancer in the elderly: why so badly treated? Lancet. 336:1990;1020-1022.
16. Fentiman I.S. Treatment of cancer in the elderly. Br. J. Cancer. 64:1991;993-995.
17. Monfardini S., Ferruci L., Fratino L., et al. Validation of a multidimensional evaluation scale for use in elderly cancer patients. Cancer. 77:1996;359-401.
18. Repetto L., Venturino A., Vercelli M., et al. Performance status and comorbidity in elderly cancer patients compared with young patients with neoplasia and elderly patients without neoplastic conditions. Cancer. 82:1998;760-765.
19. Extermann M., Balducci L. Comorbidity and functional status are independant in older cancer patients. J. Clin. Oncol. 16:1998;1582-1587.
20. Lewis M., Pearson V., Corcoran-Perry S., et al. Decision making by elderly patients with cancer and their caregivers. Cancer Nurs. 20:1997;389-397.
21. Maher M., Campana F., Mosseri V., et al. Breast cancer in elderly women: a retrospective analysis of combined treatment with tamoxifen and once-weekly irradiation. Int. J. Radiat. Oncol. Biol. Phys. 31:1995;1015-1017.
22. Mustacchi G., Milani S., Pluchinotta A., et al. Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: the GRETA Trial. Anticancer Res. 14:1994;2197-2200.
23. Martelli G., De Paolo G., Rossi N., et al. Long-term follow-up of elderly patients with operable breast cancer treated with surgery without axillary dissection plus tamoxifen. Br. J. Cancer. 72:1995;1251-1255.
24. Castellucci L. Better fundamentals- not 'razzle dazzle'- needed in cancer research on the elderly. J. Natl. Cancer Inst. 91:1999;14-16.
25. Philips K.A., Tannock I.F. Design and interpretation of clinical trials that evaluate agents that may offer protection from the toxic effects of cancer chemotherapy. J. Clin. Oncol. 9:1998;3179-3190.
26. Cleary J.F., Carbone P.P. Palliative medicine in the elderly. Cancer. 80:1997;1335-1347.
27. Byock I.R., Merriman M.P. Measuring quality of life for patients with terminal illness: the Missoula-VITAS quality of life index. Palliat. Med. 12:1998;231-244.
28. Pereira J., Macmillan A., Bruera E. Launching a palliative care homepage: the Edmonton experience. Palliat. Med. 11:1997;435-443.
29. American Society of Clinical Oncology (ASCO) Special Article. Cancer care during the last phase of life. J. Clin. Oncol. 16:1986-1996, 1998.
30. Bernabei R., Gambassi G., Lapane K., et al. Management of pain in elderly patients with cancer: SAGE study group. J. Am. Med. Assoc. 279:1998;1877-1882.
31. Leichter H.M. Oregon's bold experiment: whatever happened to rationing? J. Health Polit. Policy Law. 24:1999;147-160.
32. Glass A. The Oregon Health Plan: development and implementation of an innovative method of delivery of health care services to the medically indigent. Cancer (Suppl. 10). 82:1998;1995-1999.
33. Chantler C. The role and education of doctors in the delivery of health care. Lancet. 353:1999;1178-1181.